-transparent.png){kind=logo}
Twenty patients are described in whom liver damage appeared to be directly related to the administration of methyldopa. Sixteen had hepatitic syndromes from which they recovered on stopping methyldopa; four of these patients had recurrences of jaundice after a second course of the drug. Features suggestive of active chronic hepatitis were found in two patients. There were two deaths attributed to methyldopa, one of these being in a patient with pre-existing undiagnosed macronodular cirrhosis.
Related Publications
P J Toghill, and
P G Smith, and
P Benton, and
R C Brown, and
H L Matthews
December 1976,
The Journal of the Association of Physicians of India,
P J Toghill, and
P G Smith, and
P Benton, and
R C Brown, and
H L Matthews
March 1971,
The Medical journal of Malaya,
P J Toghill, and
P G Smith, and
P Benton, and
R C Brown, and
H L Matthews
December 1977,
European journal of clinical pharmacology,
P J Toghill, and
P G Smith, and
P Benton, and
R C Brown, and
H L Matthews
June 1970,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
P J Toghill, and
P G Smith, and
P Benton, and
R C Brown, and
H L Matthews
August 1977,
The American journal of gastroenterology,
P J Toghill, and
P G Smith, and
P Benton, and
R C Brown, and
H L Matthews
July 1967,
New York state journal of medicine,
P J Toghill, and
P G Smith, and
P Benton, and
R C Brown, and
H L Matthews
January 1981,
Scandinavian journal of gastroenterology,
P J Toghill, and
P G Smith, and
P Benton, and
R C Brown, and
H L Matthews
August 1978,
JPMA. The Journal of the Pakistan Medical Association,
P J Toghill, and
P G Smith, and
P Benton, and
R C Brown, and
H L Matthews
August 1980,
British journal of clinical pharmacology,
P J Toghill, and
P G Smith, and
P Benton, and
R C Brown, and
H L Matthews
January 1989,
Digestion,
